Abstract:Background: Epigenetic dysregulation affecting oncogenic transcription and DNA damage response is a hallmark of cancer. The histone demethylase KDM4B, a factor regulating these processes, plays important roles in estrogen receptor-mediated transcription and DNA repair in breast cancer. However, how oncogenic phospho-signal transduction affects epigenetic regulation is not fully understood. Here we found that KDM4B phosphorylation by ribosomal S6 kinase (RSK), a downstream effector of the Ras/MAPK pathway, is critical for the function of KDM4B in response to DNA damage. Methods: KDM4B-knockout breast cancer cell lines were generated via CRISPR/Cas9-mediated gene editing. Re-expression of wild-type or phospho-site mutated KDM4B in knockout cells was performed by lentivirus-mediated gene transfer. Gene knockdown was achieved by RNA interference. DNA double-strand breaks (DSBs) were induced by ionizing radiation or laser-microirradiation. Protein accumulation at DSB sites was analyzed by immunofluorescence. KDM4B phosphorylation by RSK was assessed by in vitro and in vivo kinase assays. Gene and protein expression levels were analyzed by RT‒PCR and western blotting. The sensitivity of cells to ionizing radiation was examined by a clonogenic survival assay. Results: RSK phosphorylated KDM4B at Ser666, and inhibition of the phosphorylation by RSK depletion or RSK inhibitors abrogated KDM4B accumulation at the sites of DNA double-strand breaks (DSBs). DSB repair was significantly delayed in KDM4B-knockout cells or cells treated with RSK inhibitors. The replacement of endogenous KDM4B with the phosphomimetic mutant S666D restored KDM4B accumulation and DSB repair that had been inhibited by RSK inhibitors, suggesting a critical role for RSK at the specific serine residue of KDM4B in the effect of RSK inhibitors on DSB repair. As a consequence of these aberrant responses, inhibition of KDM4B phosphorylation increased the sensitivity of the cells to ionizing radiation. Conclusions: Overall, the present study uncovered a novel function of RSK on the DNA damage response, which provides an additional role of its inhibitor in cancer therapy.

Ribosomal S6 Kinase 2 (RSK2) Maintains Genomic Stability by Activating the Atm/p53-dependent DNA Damage Pathway.

Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4B

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response

SRSF2 safeguards efficient transcription of DNA damage and repair genes

DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair

RSK2 and its binding partners in cell proliferation, transformation and cancer development

The P53 Protein Is A Novel Substrate Of Ribosomal S6 Kinase 2 And A Critical Intermediary For Ribosomal S6 Kinase 2 And Histone H3 Interaction

LRRK2 Interacts with ATM and Regulates Mdm2-p53 Cell Proliferation Axis in Response to Genotoxic Stress.

Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition

p57Kip2 is an unrecognized DNA damage response effector molecule that functions in tumor suppression and chemoresistance

SRSF2 transcriptional function maintains genome integrity during cell division

Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase–dependent manner and regulates the DNA damage response

p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival

Targeted Polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP Ligases in Response to DNA Damage

Roles of Kruppel-associated Box (Krab)-Associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response*

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer

Data from Ribosomal S6 Kinase 2 is a Key Regulator in Tumor Promoter–Induced Cell Transformation

Ribosomal Protein S27-like is a Physiological Regulator of P53 That Suppresses Genomic Instability and Tumorigenesis

Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress

Skp2 E3 Ligase Integrates ATM Activation and Homologous Recombination Repair by Ubiquitinating NBS1